Neuropace Correlations

NPCE Stock

USD 16.94 0.41 2.36%

The current 90-days correlation between Neuropace and Cerus is 0.13 (i.e., Average diversification). The correlation of Neuropace is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Neuropace Correlation With Market

Weak diversification

The correlation between Neuropace and DJI is 0.3 (i.e., Weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Neuropace and DJI in the same portfolio, assuming nothing else is changed.

Build AI portfolio with Neuropace Stock

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Neuropace. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.

For information on how to trade Neuropace Stock refer to our How to Trade Neuropace Stock guide.

Moving together with Neuropace Stock

0.73	SPEC	Inspecs Group plc	Pair Corr
0.66	EW	Edwards Lifesciences Corp	Pair Corr
0.78	BLCO	Bausch Lomb Corp	Pair Corr
0.87	ELMD	Electromed	Pair Corr
0.82	BB1	Blinklab	Pair Corr
0.9	ESTA	Establishment Labs	Pair Corr
0.7	601089	Beijing Winsunny Pha	Pair Corr

Moving against Neuropace Stock

0.89	VNRX	Volitionrx	Pair Corr
0.88	OM	Outset Medical	Pair Corr
0.73	688289	Sansure Biotech	Pair Corr
0.7	688677	Qingdao NovelBeam	Pair Corr
0.68	688606	Hangzhou Alltest Biotech	Pair Corr
0.59	300061	QITIAN Technology	Pair Corr
0.53	IPD	Impedimed	Pair Corr
0.92	OTC	Ocumetics Technology Corp	Pair Corr
0.89	POLX	Polarean Imaging Plc	Pair Corr
0.82	VVOS	Vivos Therapeutics	Pair Corr
0.77	ENOV	Enovis Corp	Pair Corr
0.74	ELAB	Elevai Labs Common	Pair Corr
0.69	EMBC	Embecta Corp	Pair Corr
0.39	VTAK	Catheter Precision	Pair Corr
0.36	300453	Jiangxi Sanxin Medtec	Pair Corr
0.78	XAIR	Beyond Air	Pair Corr
0.76	688317	Shanghai ZJ Bio	Pair Corr
0.68	AHG	Akso Health Group	Pair Corr
0.67	AHC	Austco Healthcare	Pair Corr
0.6	300482	Guangzhou Wondfo Biotech	Pair Corr
0.32	ABT	Abbott Laboratories Earnings Call This Week	Pair Corr

Related Correlations Analysis

	CERS	RXST	CVRX	MASS	BWAY	SENS	SGHT	DCTH	GNLX	ALDX
CERS		0.53	-0.89	-0.63	0.62	-0.05	0.56	0.3	-0.83	-0.51	CERS
RXST	0.53		-0.37	-0.55	-0.09	-0.43	0.87	-0.1	-0.48	-0.12	RXST
CVRX	-0.89	-0.37		0.71	-0.63	0.14	-0.49	-0.21	0.83	0.5	CVRX
MASS	-0.63	-0.55	0.71		-0.23	0.64	-0.8	0.32	0.76	0.46	MASS
BWAY	0.62	-0.09	-0.63	-0.23		0.39	-0.03	0.59	-0.59	-0.44	BWAY
SENS	-0.05	-0.43	0.14	0.64	0.39		-0.66	0.68	0.18	0.07	SENS
SGHT	0.56	0.87	-0.49	-0.8	-0.03	-0.66		-0.25	-0.59	-0.23	SGHT
DCTH	0.3	-0.1	-0.21	0.32	0.59	0.68	-0.25		-0.17	0.05	DCTH
GNLX	-0.83	-0.48	0.83	0.76	-0.59	0.18	-0.59	-0.17		0.58	GNLX
ALDX	-0.51	-0.12	0.5	0.46	-0.44	0.07	-0.23	0.05	0.58		ALDX
	CERS	RXST	CVRX	MASS	BWAY	SENS	SGHT	DCTH	GNLX	ALDX

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

SGHT	+ 0.87	RXST
GNLX	+ 0.83	CVRX
GNLX	+ 0.76	MASS
MASS	+ 0.71	CVRX
DCTH	+ 0.68	SENS
SENS	+ 0.64	MASS

High negative correlations

CVRX	- 0.89	CERS
GNLX	- 0.83	CERS
SGHT	- 0.8	MASS
SGHT	- 0.66	SENS
BWAY	- 0.63	CVRX
MASS	- 0.63	CERS

Risk-Adjusted Indicators

There is a big difference between Neuropace Stock performing well and Neuropace Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Neuropace's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
CERS	3.62	0.69	0.18	0.43	3.45	(4.47)	10.19	(6.43)	30.94
RXST	3.09	0.30	0.09	0.29	3.59	(3.27)	7.97	(5.79)	23.38
CVRX	2.87	(0.98)	0.00	(0.40)	0.00	0.00	4.04	(6.66)	28.35
MASS	2.76	(0.64)	0.00	(0.54)	0.00	0.00	5.02	(6.56)	18.30
BWAY	2.44	0.58	0.20	0.86	2.20	(2.80)	5.68	(3.68)	14.16
SENS	3.40	(0.37)	0.00	(0.04)	0.00	0.00	6.74	(7.58)	17.86
SGHT	4.02	0.89	0.31	0.36	2.97	(5.42)	10.73	(5.67)	44.62
DCTH	2.11	(0.18)	0.00	(0.12)	0.00	0.00	4.57	(4.41)	18.23
GNLX	4.52	(0.92)	0.00	(0.29)	0.00	0.00	7.03	(11.87)	54.58
ALDX	3.61	(0.09)	0.00	(0.23)	0.00	0.00	6.27	(8.84)	42.93

Neuropace Corporate Management

Irina Ridley	Chief Secretary	Profile
Chi Nguyen	VP Marketing	Profile
Kelley Nicholas	Vice Sales	Profile
Michael Favet	CEO Pres	Profile
Katie Keller	Vice Marketing	Profile
Patrick Williams	Chief Officer	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2026 Macroaxis LLC